Pidolic Acid

Pidolic Acid

SCHEMBL14859342

CCOC(=O)[C@@H]1CCC(=O)N1.O=C1CC[C@@H](C(=O)O)N1

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of Pidolic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.53
GAA P10253 2/20 0.48
TSHR P16473 1/20 0.41
PPM1B O75688 1/20 0.40
PTPN1 P18031 1/20 0.40
PPP1CC P36873 1/20 0.40
CNR1 P21554 1/20 0.38
DAGLA Q9Y4D2 1/20 0.38
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
MEN1 O00255 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
KMT2A Q03164 1/20 0.36
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL905284 0.94 LMNA (0.58) LMNAGAATSHRPPM1BPTPN1
SCHEMBL815103 0.94 LMNA (0.58) LMNAGAATSHRPPM1BPTPN1
SCHEMBL80480 0.94 LMNA (0.58) LMNAGAATSHRPPM1BPTPN1
Hydrochloric Acid SCHEMBL29400035 0.92 LMNA (0.57) LMNAGAATSHRCNR1DAGLA
Isopropyl Alcohol SCHEMBL28077462 0.88 LMNA (0.53) LMNAGAATSHRCNR1DAGLA
Pidolic Acid SCHEMBL7005448 0.85 LMNA (0.41) LMNAGAATSHRCNR1DAGLA
Pidolic Acid SCHEMBL5180306 0.85 LMNA (0.41) LMNAGAATSHRCNR1DAGLA
SCHEMBL15265428 0.84 LMNA (0.49) LMNAGAATSHRALDH1A1MAPT
SCHEMBL5992612 0.84 LMNA (0.49) LMNAGAATSHRALDH1A1MAPT
SCHEMBL13106060 0.84 LMNA (0.49) LMNAGAATSHRALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9694090-B2 Process for preparing hyperpolarized substrates and method for MRI BRACCO IMAGING S.P.A. (IT) 2017-07-04 US disclosed
US-20130096420-A1 Process For Preparing Hyperpolarized Substrates And Method For MRI BRACCO IMAGING S.P.A. (IT) 2013-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130096420-A1 Process For Preparing Hyperpolarized Substrates And Method For MRI HOGA1, HAMP, GLS2 LMNA 390/4885GAA 1236/4885TSHR 1509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.